Clinical Trial Update: Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival [NA]

View source ↗

Summary

Completed clinical trial assessing whether FDG-TEP during radiotherapy or chemoradiotherapy can predict one-year survival in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Lung Cancer, NSCLC | NA | Status: COMPLETED